+49 711 500 989 80
deen

Drug modifies epigenome in aggressive brain tumors



Drug modifies epigenome in aggressive brain tumors

The researchers showed for the first time that the DNA methylome of these brain tumors can be reprogrammed. The study said that this is the first time DNA methylome reprogramming has occurred with any solid human tumor.

Materials provided by Vanderbilt University Medical Center. Original written by Tom Wilemon. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

16th January 2022

MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer

Read more
16th January 2022

Nuclei-free cells prove utility in delivering therapeutics to diseased tissues

Read more
15th January 2022

Blood test helps predict who may benefit from lung cancer screening

Read more